Pabrik Kertas Tjiwi Kimia Tbk (TKIM)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 6,575.00 |
|---|---|
| 52-week range | 4,400.00 – 11,300.00 |
| Return, 1 month / 3 months | −11.7% / +8.2% |
| Return, 1 year / 3 years | −7.2% / −18.3% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 58.3% |
| Worst drawdown (1 year) | -59.4% |
| Average daily value traded | 20,166.12M IDR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pabrik Kertas Tjiwi Kimia Tbk is an Indonesian pulp and paper manufacturer based in Sidoarjo, East Java. It makes writing and printing paper, packaging papers and board, tissue products and stationery, and also produces pulp. Its customers include converters, printers, publishers and consumer goods companies, and it exports much of its output to markets around the world. The company belongs to the Sinar Mas group and operates integrated mills that turn wood pulp into finished paper goods.
Pabrik Kertas Tjiwi Kimia Tbk trades under the code TKIM on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pabrik Kertas Tjiwi Kimia Tbk (TKIM) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 6,575.00 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 329 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.2% and over the last three months it rose 8.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.2% | ||
| From 52-week high | -41.3% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.2% | ||
| 6-month return | -25.7% | ||
| 12-month return, skipping the last month | 5.1% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -59.4% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 20,166.12M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +8.7% |
|---|---|
| 1 month | −11.7% |
| 3 months | +8.2% |
| 6 months | −25.7% |
| 1 year | −7.2% |
| 3 years | −18.3% |
| 5 years | −22.1% |
Signals
| 50-day / 200-day average | 7,497.50 / 7,402.15 |
|---|---|
| Golden / death cross (60 days) | Golden, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 342.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jul 2026 | IDR 30.0000 |
| 25 Jun 2025 | IDR 25.0000 |
| 28 Jun 2024 | IDR 25.0000 |
| 26 May 2023 | IDR 25.0000 |
| 21 Jun 2022 | IDR 25.0000 |
| 6 Sep 2021 | IDR 25.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.